Lv, F., Si, W., Xu, X., He, X., Wang, Y., Li, Y., & Li, F. (2024). RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells. Elsevier.

Lv, Fengxu, Wentao Si, Xiaodan Xu, Xiaogang He, Ying Wang, Yetian Li, and Feifei Li. RUNX2 Prompts Triple Negative Breast Cancer Drug Resistance Through TGF-β Pathway Regulating Breast Cancer Stem Cells. Elsevier, 2024.

Lv, Fengxu, et al. RUNX2 Prompts Triple Negative Breast Cancer Drug Resistance Through TGF-β Pathway Regulating Breast Cancer Stem Cells. Elsevier, 2024.